TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 53 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Jump Financial, LLC | 16,917 | $38,232 | 0.00% |
| Tower Research Capital LLC (TRC) | 11,018 | $25 | 0.00% |
| Cubist Systematic Strategies, LLC | 40,301 | $91,080 | 0.00% |
| Maven Securities LTD | 15,000 | $33,900 | 0.00% |
| Kovitz Investment Group Partners, LLC | 15,000 | $34 | 0.00% |
| FMR LLC | 3,204,922 | $7,243,124 | 0.00% |
| FRANKLIN RESOURCES INC | 811,069 | $1,833,016 | 0.00% |
| JPMORGAN CHASE & CO | 1,782 | $4 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 50,376 | $113,850 | 0.00% |
| MONEY CONCEPTS CAPITAL CORP | 115 | $260 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,268 | $2,866 | 0.00% |
| NORTHERN TRUST CORP | 72,958 | $164,885 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 444 | $1,003 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 331,741 | $749 | 0.00% |
| STATE STREET CORP | 229,840 | $519,438 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 386,589 | $874 | 0.00% |
| MARSHALL WACE, LLP | 69,296 | $156,609 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 16,140 | $36,476 | 0.00% |
| GOLDMAN SACHS GROUP INC | 12,127 | $27,407 | 0.00% |
External links
This page lists TAYSHA GENE THERAPIES INC's shareholders in Q4 2022. To view TAYSHA GENE THERAPIES INC's shareholder history, click here.